Journal of Pediatric Psychology Advance Access originally published online on June 7, 2007
Journal of Pediatric Psychology 2007 32(6):695-710; doi:10.1093/jpepsy/jsm023
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2007 by the Ambulatory Pediatric Association, published by Elsevier Inc.
ADHD Service Use Patterns in Youth
1Child & Adolescent Services Research Center (CASRC), Pediatrics Department at the University of California, San Diego, and Graduate School of Public Health at San Diego State University, San Diego, Calif USA and 2Department of Pediatrics, Oklahoma University Child Study Center, University of Oklahoma Health Sciences Center USA.
All correspondence concerning this article should be addressed to Laurel K. Leslie, MD, Child & Adolescent Services Research Center, Children's Hospital San Diego, 3020 Children's Way MC 5033, San Diego, CA 92123. lleslie{at}casrc.org.
 |
Abstract |
|---|
 Top Abstract Sectors Serving Youth with...Service Use Among Youth...Implications for Future Research...ConclusionsAPPENDIXAcknowledgmentsReferences |
|---|
Objective To review what is currently known about service use by youth with attention-deficit/hyperactivity disorder (ADHD) and discuss research and policy implications. Methods Literature review. Results The primary care, mental health, and educational service system sectors all play an essential role in caring for youth with ADHD. Recent studies also suggest increasing use of stimulants and other psychoactive medication for youth with ADHD, decreasing mental health visits for ADHD unassociated with medication use, increased use of other psychotropic medications, and a number of barriers to care coordination across primary care, mental health, and schools. Conclusions Four important services, research, and policy areas that need to be addressed over the next decade include: 1) delving deeper into current service use, 2) paying attention to the context in which service use occurs, 3) operationalizing evidence-based care for real-world settings, and 4) learning what changes clinician and educator behavior.
Key words: ADHD; attention-deficit/hyperactivity disorder; education; primary care; service utilization; specialty mental health; stimulants..
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurobiological disorders of childhood and adolescence with a prevalence rate of ADHD among US youth ranging from 3% to 16%, depending on the sampling design and restrictiveness of the definition of ADHD used.1
Its core symptoms include hyperactivity, impulsivity, and/or inattention. Coexisting mental health disorders and learning disorders are common,1,2 and the presence of comorbid mental health disorders predicts persistence of ADHD into adulthood as well as poorer outcomes.3–6 The impact of ADHD can include academic failure, strained peer and family relations, poor self-image, delinquency, and low occupational performance.7,8 Similarly, ADHD can affect the diagnosed child's family, with associated direct and indirect costs.9–11 Fortunately, 2 evidence-based treatments for ADHD, psychotropic medications (predominantly the stimulant medications) and psychosocial interventions implemented in the home and school settings, have been extensively studied, and both treatment strategies, either alone or in combination, are effective in reducing ADHD symptoms.12–14 In addition, diagnostic and treatment guidelines have been published by the American Academy of Child and Adolescent Psychiatry (AACAP) and the American Academy of Pediatrics (AAP).15–18
The high prevalence rate of ADHD and its chronic nature suggest that youth with this disorder may have high rates of health-related service use and health care costs. In fact, compared with youth without ADHD, youth with ADHD are more likely to use psychotropic medications and to access primary care, emergency, mental health, social, and special education services.19–24 Youth with ADHD also incur health-related costs at least 2 times those of youth without ADHD.25–27
Identifying factors related to service use is critical for a number of reasons. First, understanding service use allows for resource planning and allocation, important during times of economic constraints on health care. Second, services research allows for the identification of areas of unmet need and factors that may cause discrepancies in service use. Last, understanding current service use patterns allows for better tailoring of guidelines published by professional organizations and for targeted advocacy regarding the unique health care needs of youth with this disorder.
This article provides a review of service use for youth with ADHD (Appendix). We first detail the role of the primary care, mental health, and educational sectors in the care for youth with ADHD. We next review the types of services youth with ADHD may receive including diagnostic evaluations, psychotropic medications (prescribed by either a primary care clinician or mental health professional), specialty mental health visits, and school services. When possible, we discuss trends in use over time as well as child, family, and community factors that have been found to be associated with service use. We close with a discussion of the implications of these findings for future research and policy decision-making regarding service use among youth with ADHD.
|
Sectors Serving Youth with ADHD |
|---|
|
TopAbstractSectors Serving Youth with...Service Use Among Youth...Implications for Future Research...ConclusionsAPPENDIXAcknowledgmentsReferences |
|---|
Three major sectors provide health-related services to youth with ADHD: the general medical sector, the specialty mental health sector, and the educational sector. Primary care clinicians conduct the majority of visits for ADHD and prescribe the most stimulant medications.28–32
The preponderance of care for youth with ADHD in primary care is hypothesized to relate to a number of factors including the high prevalence rate which exceeds the capacity of mental health services, an increasing focus on the neurobiological underpinnings of ADHD, the role of the primary care clinician as gatekeeper, the development of ongoing relationships between families and primary care clinicians, limitations in access to mental health services under managed behavioral health care, and negative societal attitudes toward mental illness.33
Specialty mental health services also play an important role in the care of the child with ADHD, providing access to medication as well as behavioral management strategies. These strategies have shown significant empirical support in the literature,34 appear to affect domains of impairment beyond core ADHD symptoms,13 and appear to have positive effects particularly when comorbidities are present.35–37 In addition, some have postulated that there exists an important differential between youth with ADHD served in primary care as opposed to specialty mental health sectors, with psychiatrists and other mental health professionals treating youth who are more severely impaired than those cared for in primary care settings.38–42 However, one recent case-control study10 comparing correlates of ADHD among youth seen in pediatric and psychiatric clinics in the New England area suggested similar levels of comorbidity and dysfunction between the 2 groups. Although studies of the differences in the rate of comorbidities between primary care and mental health patients have resulted in conflicting findings, it is clear that there is a high rate of comorbidity in both sectors.
School-based services are also critical to examine for a number of reasons. First, the behaviors observed in ADHD are contextually driven and may manifest themselves more in concentration-demanding situations like school, making communication with school personnel essential for the diagnosis of ADHD.15,17 Second, findings from the Multimodal Treatment Study of Children With ADHD (MTA study) suggest that tightly titrated medication use, requiring close communication between the prescribing clinician and the child's teacher, yields improved outcomes over standard community care.12 Teachers' input is thus essential for determining an effective dosing regimen and monitoring side effects. Third, there is a solid evidence-base for the effectiveness of highly structured behavioral management strategies implemented by school staff in addressing many of the common areas of dysfunction present in children with ADHD,37 particularly for more intensive programs in special class settings. In addition, through both the Individuals with Disabilities Education Act43 and Section 504 of the Rehabilitation Act,43 school systems are mandated to provide accommodations in the mainstream classroom and special education classes. In 1991, the US Department of Education also stated that individuals with ADHD could be considered disabled under the "Other Health Impaired" categorization,44 potentially increasing access to school-based services for youth with ADHD.
Unfortunately, communication across sectors occurs infrequently39,42,45,46 due to differences in cultures, languages, and schedules across sectors; little to no reimbursement for the time required for effective communication; confidentiality requirements in both the health (Health Insurance Portability and Accountability Act) and school (Family Educational Rights and Privacy Act) systems; and limited community and school resources. Attempts at enhancing communication have had limited effects.46 The recent growth in school-based health clinics47 may provide an opportunity for collaborative care for youth with ADHD.
|
Service Use Among Youth with ADHD |
|---|
|
TopAbstractSectors Serving Youth with...Service Use Among Youth...Implications for Future Research...ConclusionsAPPENDIXAcknowledgmentsReferences |
|---|
Service use for ADHD includes a variety of service types. These include diagnostic/evaluative services as well as treatment services including medication, office visits, and school-based services. Recent data on these types of services are reviewed below and summarized in the Appendix.
Diagnostic/Evaluative Services
Because of the inherent difficulties in distinguishing between evaluation and treatment services using parental report or administrative records, few studies report on diagnostic services. Hoagwood and colleagues'48 analysis of the National Ambulatory Medical Survey (NAMCS) found that diagnostic services increased overall from 22.3% in 1989 to 62.1% in 1996, with the largest increase from 1989 to 1991. Large differences between provider types were found with diagnostic/evaluative services noted on 80.6% of visits to psychiatrists, 64% to pediatricians, and 32.6% to family practitioners. Whether this variation reflects actual differences in the delivery of diagnostic services or only a difference in conceptualization and coding of visits is unclear.
Several studies have been undertaken to describe practice patterns with respect to the content of diagnostic services in primary care settings and have found limited use of diagnostic instruments.41,49 Research has also suggested it is difficult for primary care providers to collect information from a second source, such as the school setting.42,45 Two studies have also looked at child and family-level factors that may influence receipt of diagnostic/evaluative services. Stevens and colleagues,50 using 1995–2000 data from the NAMCS and National Hospital Ambulatory Medical Care Survey, found that latency age was more likely to be associated with receipt of a diagnosis than preschool or adolescent age. Medicaid insurance coverage was also positively associated with receipt of a diagnosis, compared with both private and no insurance. Complex interactions were noted between geographic regions, race/ethnicity, and whether or not an ADHD diagnosis was likely to be recorded at a visit. A recent Centers for Disease Control analysis of 2003–2004 data from the National Survey of Children's Health found that male gender, higher family education level, geographic location, insurance coverage, and non-Hispanic, English-speaking racial/linguistic backgrounds were more often associated with receipt of a diagnosis.51
Psychotropic Medication Use
Psychotropic medications, particularly the stimulant medications, play a critical role in the management of the child with ADHD. In fact, stimulants represent the treatment of choice for ADHD by most physicians.52 The efficacy of the stimulant medications in decreasing ADHD core symptoms has been adequately demonstrated in a number of studies.13,53,54 Although public controversy regarding the use of medications for ADHD continues in the public press,55,56 a national consensus statement from the National Institutes of Health,57 published professional guidelines regarding evidence-based use of the stimulant medications,18,58 and outreach to the lay public by groups such as Children and Adults With ADHD have increased public awareness and acceptance.
Paralleling this increased awareness of medication as a viable treatment option for ADHD has been a substantial increase in the use of psychotropic medications over the last decade, especially in the US. Hoagwood and colleagues' analysis of the NAMCS data for the time interval from 1989 to 1996,48 Zito and colleagues' data on 900 000 youths enrolled in 2 US health care systems,59 and Safer and colleagues' studies using Baltimore County School District data60,61 have all noted an increase in the use of stimulants. Contrastingly, Olfson and colleagues' comparison between the 1987 parent-reported National Medical Expenditure Survey and its subsequent version, the 1997 Medical Expenditure Panel Survey, found no significant difference in the proportion of treated children who received stimulants but did note an increase in the use of other psychotropic medications, particularly clonidine.62 These contrasting findings may reflect the fact that medication use was measured using different data sources. Alternatively, as Olfson and colleagues suggest, the proportion of youth with ADHD who are being treated may not have changed but youth are being treated more consistently, with higher overall doses, and over a longer period of time.
Research has documented considerable variation in medication use, raising concerns of both inappropriate and under utilization of these medications. For example, higher rates of stimulant use have been associated with child characteristics including male gender,48,51,63–70 latency age,51,63,67,68,71 and presence of impairment.64 Insurance status has been linked to stimulant medication use.65,71,72 Participation in special education, particularly programs for youth with emotional handicaps, has also been linked to receipt of medication.60,65,70 Similarly, receipt of mental health counseling has been associated with medication use.73,74
Research has also documented considerable geographic variation, with respect to stimulants. Jensen and colleagues'75 study of 4 communities in the Methods for Epidemiology of Child and Adolescent Mental Disorders Study found that 5.1% of youths met criteria for ADHD but only 12.5% of these youths reported past-year stimulant use. Contrastingly, Angold and colleagues'76 Great Smoky Mountains study indicated that almost three-quarters of children with a diagnosis of ADHD received stimulants. Research by Rowland and colleagues,69 Zito and colleagues,77 Rappley and colleagues,28 Shatin and Drinkard,78 and Hoagwood and colleagues48 has also demonstrated geographic variation. Community factors have been implicated; claims data from a commercially insured sample of youths demonstrated that higher income communities and greater proportions of white children are associated positively with use.67
In addition, differences in prescription rates have been found by race/ethnicity in a number of studies.50,5165,71,73 For example, Hoagwood and colleagues73 found discrepancies in medication use in the 1995–2000 NAMCS data, with whites nearly 9 times as likely to receive a prescription for stimulant medication compared with others, even when age, gender, length of visit, and insurance coverage were controlled. Stevens and colleagues also examined the effect of race/ethnicity on stimulant medication use with 1997–2000 Medical Expenditure Panel Survey data71 and found that African-Americans were less likely to be diagnosed with ADHD and to initiate stimulant medication treatment compared with whites. Stevens and colleagues'50 reanalysis of the 1995–2000 data from NAMCS found that both diagnosis and prescriptions for psychotropic medications were less likely for Hispanics compared with whites. Importantly, their work suggested that no differences by ethnicity in medication use were noted once an ADHD diagnosis was made, suggesting that discrepancies in medication use by race/ethnicity may partially relate to the identification process. These differences in prescription use by race/ethnicity may reflect access to care issues such as insurance, transportation, and other barriers to care.
Discrepancies by race/ethnicity may also relate to important differences in cultural constructs regarding deviant behavior, help-seeking, and appropriate treatments, as parental belief that a child needs mental health treatment is the most important factor associated with service use in all populations.79 There is some evidence that the threshold for what is considered dysfunctional varies across cultures.80,81 Research to date exploring differences in cultural attitudes regarding stimulant medication is in its infancy but does suggest important differences.82,83
Differences in medication use could also relate to provider propensity to prescribe these medications. Hoagwood and colleagues'48 analyses of the NAMCS data from 1989 to 1996 found significant differences by provider types with three-fourths of psychiatrists and pediatricians prescribing stimulants to children diagnosed with ADHD compared with 94.9% of family practitioners. There are no studies published to date examining possible cultural determinants of physician prescribing behavior, although this is theoretically possible.
More recent studies have examined the longitudinal use of stimulant medications. These studies, regardless of the characteristics of their sample, suggest limited adherence to stimulant medication treatment regimens for ADHD.64,66,84 For example, Habel and colleagues'32 examination of administrative data from a large California health plan found that, of the 11 698 children receiving at least one stimulant in 2000, 24% received a single prescription. Factors associated with limited adherence have not been extensively studied.
In summary, although the use of stimulant medication has been increasing, its use remains highly variable. Factors such as geographical location, race/ethnicity, and economic status appear to be determinants of its use and physician practices are far from uniform. Several studies have suggested that some differences in stimulant medication use may be decreasing for girls relative to boys,59,61 in adolescents relative to latency age children,59,61 and for African-Americans compared with whites.59 Limited studies available suggest poor compliance among youth taking stimulant medications, although factors affecting adherence have not been extensively investigated. In addition, there is an increasing trend to use other psychotropic medications, either alone or in combination with the stimulant medications.
Office Visits
The data on office visits for ADHD comes primarily from large administrative data sets or from national surveys of families or providers. The most comprehensive national study to date is Hoagwood and colleagues'48 analyses of the NAMCS data which allow for examination of differences in care by provider type. Although data from 1989 to 1996 demonstrated an increase in the total percentage of visits to physicians where ADHD was identified, several disturbing trends were noted. First, there was a 45% decrease in the total percentage of visits where no drugs were prescribed, from 23.4% of visits in 1989 to 12.8% of visits in 1996. Second, there was an overall decrease in the percentage of visits where children received psychotherapy, from 40.1% of total visits in 1989 to 25.2% in 1996. Similarly, the total percentage of visits where follow-up services were recommended decreased from 91% in 1989 to 75.1% in 1996. Follow-up services differed by provider type with psychiatrists and pediatricians more likely to recommend follow-up visits compared with family practitioners.
Hoagwood and colleagues'48 review of data from the Child Behavior Study (CBS) is one of the few studies to look at the service mix for children cared for in primary care. The CBS includes a representative sample from a national pediatric practice network (Pediatric Research in Office Settings) and a national family practice network (Ambulatory Sentinel Practice Network). These primary care clinicians reported that 27.5% of children seen received no counseling, medications or referrals, 27% received counseling and medications, 17% receiving medications only and 11.5% received counseling only. Common barriers to care cited by participating physicians included lack of pediatric specialists, difficulty or delay in getting appointments, physician panel restrictions, complex appeals processes, and insufficient supply of Medicaid providers.
Stein and Orlando85 examined service mix in the mental health sector by studying claims data from 104 employer groups whose behavioral health care benefits were managed by United Behavioral Health, the third largest behavioral health care organization in the US. For their analyses, they excluded those children only cared for in the primary care sector or whose visits were limited to 1–2 sessions with a therapist. Their analyses demonstrated that the average number of visits for patients whose treatment was split between a therapist and a psychiatrist was almost twice that of a patient receiving treatment from either a therapist or psychiatrist, leading them to posit that "splitting treatment" between 2 providers may be less cost-effective.
As there is a strong evidence-base for the use of behavior modification for ADHD and other disruptive disorders,34 efforts to improve quality care should address the use of these methodologies in office visits. However, only a limited investigation regarding the content of visits has been carried out. A number of other interventions have been widely used including play therapy, individual insight therapy, cognitive behavioral therapies, biofeedback, and dietary interventions, but there is little support for their effectiveness in the literature.57 One recent study did inspect adherence to quality indicators for the outpatient care of ADHD, conduct disorder and major depression, including the use of behavior modification, for 813 children seen in 62 mental health clinics in California from August 1, 1998, through May 31, 1999. High adherence was documented for clinical assessment (78%–95%) for all 3 disorders. With respect to treatment of ADHD, a majority of charts indicated a referral for a medication evaluation (84%, SE = 2.32), but the use of evidence-based behavioral therapy (i.e., contracts, incentive systems, contingency management, parent training) was rated at 8.4% (SE = 2.53).86 The actual content of mental health visits for ADHD in these real-world settings and what proportion of care provided builds on an existing database deserves further exploration.
Results from the studies above documenting relatively fewer overall visits per child suggest a trend toward increased use of medication and decreased intensity of psychotherapeutic visits. The content and quality of available visits is still not known.
School-based Services
Relatively little data are available regarding the use of school-based services by children with ADHD. Only a limited number of studies62,64,66,75 have examined school service use, all have relied on parental report, and most have found service rates in the 25% range. Bussing and colleagues'66 study of ADHD service use in a district sample suggested that African-American youth were more likely to receive school services than white children. Although these studies suggest a possible estimate of the prevalence rates of school-based services for children with ADHD, they do not allow for the examination of trends in service use over time or for extensive investigation of possible variation in service use related to child, family, or community characteristics as has been noted for both stimulant medication and for office visits.
In addition, limited research has been undertaken to examine the content, quality, and effectiveness of interventions currently available in existing school settings. The Department of Education is under considerable scrutiny by Congress to assure that educational services provided are a good investment of public monies. More evaluation of school-based services for ADHD should be forthcoming.87
Summary
It is clear that the current service use for youth with ADHD is highly variable and that, whereas good evidence-based information is available about diagnosing and treating children with ADHD, much still needs to be done in order to translate the science into practice and improve the care of children with this condition. In addition, data regarding trends over time and factors affecting service use are much more detailed for medication use than for mental health visits. Finally, there is a serious paucity of available literature regarding service use in the educational sector.
|
Implications for Future Research and Policy |
|---|
|
TopAbstractSectors Serving Youth with...Service Use Among Youth...Implications for Future Research...ConclusionsAPPENDIXAcknowledgmentsReferences |
|---|
The previous sections have reviewed what is currently known about service use by youth with ADHD. Some clear limitations of the above-mentioned studies stand out. First, several of the studies reviewed that used administrative data sets have called for linkages with clinical data in order to validate diagnoses and allow for more precise descriptions of services for youth with ADHD, controlling for associated comorbidities. Second, few of the studies reviewed above have examined trends in service use following publication of the MTA study findings (1999 to date), the AACAP ADHD guidelines (1997), the AAP ADHD guidelines (2000, 2001), or efforts by the National Initiative for Children's Healthcare Quality, the Texas Medication Algorithm Project, and other groups to apply quality improvement processes to ADHD care in primary care and specialty mental health. Clearly, more up-to-date information is needed. Last, the lack of research on service use in the educational sector for youth with ADHD is striking, particularly in comparison to the literature available on stimulant medication use.
In this next section, we begin to identify some of the additional research and policy areas that need to be prioritized over the next decade as we continue to try to understand and then make informed policy decisions aimed at improving service delivery for youth with ADHD in usual care settings. We have grouped these into 4 overall domains: 1) delving deeper into current service use, 2) operationalizing evidence-based ADHD care in real-world settings, 3) learning what changes clinician and educator behavior, and 4) paying attention to contextual factors that may affect service use.
Delving Deeper Into Current Service Use
Several of the findings described above—the variation in stimulant medication use, the role of outpatient mental health settings and schools as primary sources of mental health care for youths with ADHD, the suggested under-utilization of evidence-based practice in public mental health—raise important questions regarding characteristics of currently available services. Studies are needed that examine the content and quality of services currently provided in the primary care, mental health, and educational sectors. Better delineation of content of care would also allow for more in-depth examination of the effectiveness of services currently utilized in these real-world settings. This type of data would also provide for a rich description of usual care procedures from which to work to develop community-based interventions to improve outcomes of ADHD care in these settings.
These types of studies require the use of novel research methodologies and approaches. Recently, pediatric mental health services researchers have called for hybrid practice research that uses techniques developed by intervention researchers to characterize treatment processes and examine how variations in treatment strategies relate to treatment outcomes within the context of usual community-based care settings.88 These researchers have pushed for the development of rigorous measurement methods for characterizing the approaches that clinicians take to working with youth and families, including the self-report of aspects of services provided,89 parental reports, or the use of independent observers who view videotapes and code visits.90–94 Qualitative and case-based methodologies drawn from the fields of anthropology and business may also provide novel models for this type of research.
Operationalizing Evidence-Based ADHD Care in Real-World Settings
As important as the descriptive studies of available care called for above are studies that begin to examine the core content and dosage of evidence-based ADHD care in efficacy studies and the operationalization of these components for usual care settings. Efficacy studies like the MTA provide important information for organizations seeking to develop guidelines for care of conditions like ADHD. However, the translation of care given during a research study to the clinical setting is often complicated by difficulties in operationalizing a research protocol to real-world settings.
As attempts are made to operationalize evidence-based care in usual care settings, it will be important to consider how to translate an interventional process from an efficacy trial across the 3 usual care settings of primary care, mental health, and schools. For example, the availability of informal consultative services by subspecialists as well as ready access to clinicians trained in behavioral modification in the home and school settings will be essential. This will require creative, efficient, and effective mechanisms developed for organizing behavioral health care services that span primary care, specialty, and educational services.
Learning What Changes Clinician and Educator Behavior
To assist providers in implementing and tailoring diagnosis and treatment guidelines, it will be important to understand what factors lead to changes in practice patterns across these 3 settings. The literature on the effectiveness of continuing medical education and on technology transfer make clear that although education is important, providing information to practitioners is seldom enough to encourage appropriate changes in practice, even when information has been successfully disseminated to an appropriate target audience.95–97
The challenge of changing physician behavior was kept in mind when the AAP planned its effort to develop training initiatives with regard to ADHD. Through partnerships between the AAP, the North Carolina Center for Children's Healthcare Improvement, the Agency for Healthcare Research and Quality, and the National Initiative on Child Healthcare Quality, the AAP has developed the ADHD guidelines, an ADHD toolkit, and an interactive on-line training module on ADHD care in the primary care office setting, and has shepherded pediatric offices across the country through the process of implementing the ADHD guidelines.
The AAP approach utilized adult learning principles, systems change approach, a chronic illness model, and a feedback system (registry). Feedback from the offices participating in the process has been positive; interestingly, those practices who report the most success were able to find partners in the school and mental health systems and in the administration of their service system to address issues of implementation and sustainability. Although the approach appears conceptually and anecdotally promising, a rigorous assessment of its effectiveness at changing clinical behavior patterns and, more distally, outcomes for youth with ADHD, has yet to be completed.
Paying Attention to Contextual Factors
Lastly, studies are needed that characterize and incorporate the context in which these services are being delivered in their research design. Three recent publications, The National Institute of Mental Health's Blueprint for Change: Research on Child and Adolescent Mental Health,98 the Surgeon General's National Action Agenda for Children's Mental Health,99 and a review by Hoagwood and colleagues entitled "Evidence-Based Practice in Child and Adolescent Mental Health Services"100 have pushed the health services research field conceptually with regard to deploying evidence-based practice into real world settings. All 3 publications state that implementation of evidence-based practice into these settings may fail unless contextual factors are built into the long-term design of new services. These critical factors need further elucidation in designing interventions to implement ADHD care in real-world settings, including the characteristics of the youth served and families served in a particular venue. Especially important to this discussion are possible cultural differences in threshold for deviant behavior, care-seeking from the general medical sector, and attitudes regarding appropriate treatment.
System characteristics also need to be examined. The reported high prevalence rate of ADHD indicates that the sheer number of youth with the disorder is too great for these youth to be feasibly treated by the mental health community alone and will require partnership with primary care. In addition, because many of the behaviors that youth with ADHD exhibit are manifested and managed while they are in school, the educational system also plays a vital role. Care then requires participation and collaboration among the primary care, mental health and educational communities.
There are several challenges to service delivery within the 3 service systems discussed in this paper. In the primary care sector, these barriers include limited training during residency in the diagnosis and management of developmental and behavioral problems, limited time to provide diagnostic or intensive treatment services in the current reimbursement system, and limited access to mental health services for consultation and referral (further exacerbated by the carving out of managed care, and limited contact with schools).46,101 In mental health, the data reviewed above suggest limited support for ongoing psychosocial interventions with an increased focus on medication management. In both primary care and mental health, increasing administrative and financial incentives and barriers imparted by third-party payers may affect clinician treatment plans, constrain referrals, and provide inadvertent disincentives to see youth with significant impairment. These programmatic changes in the health care system threaten the ability to develop multifaceted, longitudinal approaches to improving care for children with mental health problems, such as the incorporation of allied professionals within the primary care setting or the provision of case management with other sectors of care, including schools, social services, and other groups. The educational sector faces its own challenges, including demands for increasing academic accountability under the No Child Left Behind Act, budget decreases in the majority of states, and limited training regarding evidence-based behavior modification or other educational interventions during teacher certification programs.
Providing high quality ADHD care will necessitate a number of changes in our current delivery systems. Research examining these and other factors related to the youth, families, and service systems will be critical to conduct in order to understand the impact of these factors on service use and stimulate creative policy and implementation strategies for improving care in real-world settings. In addition, demonstration projects that allow for creative, flexible funding for collaborative service provision theoretically could provide important cost-benefit data regarding coordinated, cross-sector care. In addition, any research conducted must include policy outcomes that are meaningful to large systems. Models include the recent examination of an administrative data set from a national Fortune 100 manufacturer examining the cost of lost work time caring for a child with ADHD11 and a survey of employers' knowledge and attitudes about ADHD.102
Evaluation of the effectiveness of these system design changes will require the collection of sophisticated utilization data and charges using clinical information systems. Innovative research methodologies that can account for clustering and address multilevel analytic techniques and small sample sizes at the level of the organization will need to be used.
|
Conclusions |
|---|
|
TopAbstractSectors Serving Youth with...Service Use Among Youth...Implications for Future Research...ConclusionsAPPENDIXAcknowledgmentsReferences |
|---|
Despite a large research base regarding its diagnosis and treatment, the care of youth with ADHD faces a number of challenges, including the interplay of service delivery among primary care, mental health, and educational service systems. Mental health services research plays a critical role in identifying current practice patterns and barriers to the delivery of evidence-based care. More in-depth research regarding the content and quality of effectiveness of care in usual settings is needed. Clearer delineation of youth, family, and service systems characteristics and their impact on usual care also needs to be determined, as does operationalization of efficacy research protocols for real-world settings. Implementation research regarding evidence-based practice that includes system perspectives and incorporates all 3 sectors will be essential. Addressing these policy-relevant research questions will catalyze the development of innovative, creative solutions that take into account the chronic, cross-sector characteristics of ADHD care.
|
APPENDIX |
|---|
|
TopAbstractSectors Serving Youth with...Service Use Among Youth...Implications for Future Research...ConclusionsAPPENDIXAcknowledgmentsReferences |
|---|
Literature Review of Service Use by Youth With Attention-Deficit/Hyperactivity Disorder (ADHD)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Acknowledgments |
|---|
|
TopAbstractSectors Serving Youth with...Service Use Among Youth...Implications for Future Research...ConclusionsAPPENDIXAcknowledgmentsReferences |
|---|
Supported in part by National Institute of Mental Health grant K08-MH64816. We thank Brenda Bantados, Sasha Beram, and Amy Monn for their research and editorial assistance.
|
Footnotes |
|---|
ADHD Special Issue, reprinted by permission from Ambulatory Pediatrics, Vol. 7, Number 2 (Supplement), Jan./Feb. 2007,
Received December 5, 2005; accepted May 14, 2006
|
References |
|---|
|
TopAbstractSectors Serving Youth with...Service Use Among Youth...Implications for Future Research...ConclusionsAPPENDIXAcknowledgmentsReferences |
|---|
1 Green M, Wong M, Atkins D, et al. Diagnosis of Attention-Deficit/Hyperactivity Disorder: Technical Review 3. In: Agency for Health Care Policy and Research publication 99-0050, US Department of Health and Human Services, Agency for Health Care Policy and Research, Rockville, Md (1999).
2 Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry (1991) 148:564–577.
3 Biederman J, Faraone SV, Milberger S, Jetton JG. Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder? Findings from a four-year follow-up study of children with ADHD. J Am Acad Child Adolesc Psychiatry (1996) 35:1193–1204.[CrossRef][Web of Science][Medline]
4 Jensen PS, Martin D, Cantwell DP. Comorbidity in ADHD: implications for research, practice, and the DSM-IV. J Am Acad Child Adolesc Psychiatry (1997) 36:1065–1079.[CrossRef][Web of Science][Medline]
5 Pliszka SR. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. J Clin Psychiatry (1998) 59:50–58.
6 Spencer T, Biederman J, Wilens T. Attention-deficit/hyperactivity disorder and comorbidity. Pediatr Clin North Am (1999) 46:915–927.[CrossRef][Web of Science][Medline]
7 Fergusson DM, Lynskey MT, Horwood LJ. Attentional difficulties in middle childhood and psychosocial outcomes in young adulthood. J Child Psychol Psychiatry (1997) 38:633–644.[Web of Science][Medline]
8 Fischer M, Barkley RA, Fletcher KE, Smallish L. The adolescent outcome of hyperactive children: predictors of psychiatric, academic, social, and emotional adjustment. J Am Acad Child Adolesc Psychiatry (1993) 32:324–332.[Web of Science][Medline]
9 Barbaresi W, Katusic S, Colligan R, et al. How common is attention-deficit/hyperactivity disorder? Towards resolution of the controversy: results from a population-based study. Acta Paediatr (2004) 93:55–59.
10 Busch B, Biederman J, Cohen LG, et al. Correlates of ADHD among children in pediatric and psychiatric clinics. Psychiatr Serv (2002) 53:1103–1111.
11 Swensen AR, Birnbaum HG, Secnik K, et al. Attention-deficit/hyperactivity disorder: increased costs for patients and their families. J Am Acad Child Adolesc Psychiatry (2003) 42:1415–1423.[CrossRef][Web of Science][Medline]
12 Jensen PS, Hinshaw SP, Swanson JM, et al. Findings from the NIMH multimodal treatment study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr (2001) 22:60–73.[Web of Science][Medline]
13 MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (1999) 56:1073–1086.
14 MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder. Arch Gen Psychiatry (1999) 56:1088–1096.
15 American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (1997) 30:85–121.
16 American Academy of Child and Adolescent Psychiatry. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2002) 41:537.
17 American Academy of Pediatrics. Clinical practice guidelines: diagnosis and evaluation of children with attention-deficit/hyperactivity disorder. Pediatrics (2000) 105:1158–1170.
18 American Academy of Pediatrics. Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics (2001) 108:1033–1044.
19 DeBar LL, Lynch FL, Boles M. Healthcare use by children with attention deficit/hyperactivity disorder with and without psychiatric comorbidities. J Behav Health Serv Res (2004) 31:312–323.[CrossRef][Medline]
20 Brehaut J, Miller A, Raina P, McGrail K. Childhood behavior disorders and injuries among children and youth: a population-based study. Pediatrics (2003) 111:262–269.
21 Hoare P, Beattie T. Children with attention deficit hyperactivity disorder and attendance at hospital. Eur J Emerg Med (2003) 10:98–100.[CrossRef][Medline]
22 Kelleher K, Childs G, Harman J. Healthcare costs for children with attention-deficit/hyperactivity disorder. Econ Neurosci (2001) 3:60–63.
23 Offord DR, Boyle MH, Fleming JE, et al. Ontario Child Health Study: summary of selected results. Can J Psychiatry (1989) 34:483–491.[Web of Science][Medline]
24 Szatmari P, Offord DR, Boyle MH. Correlates, associates impairments and patterns of service utilization of children with attention deficit disorder: findings from the Ontario Child Health Study. J Child Psychol Psychiatry (1989) 30:205–217.[Web of Science][Medline]
25 Chan E, Zhan C, Homer CJ. Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey. Arch Pediatr Adolesc Med (2002) 156:504–511.
26 Guevara J, Lozano P, Wickizer T, et al. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics (2001) 108:71–78.
27 Leibson CL, Katusic SK, Barbaresi WJ, et al. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA (2001) 285:60–66.
28 Rappley MD, Gardiner JC, Jetton JR, Houang RT. The use of methylphenidate in Michigan. Arch Pediatr Adolesc Med (1995) 149:675–679.
29 Ruel JM, Hickey CP. Are too many children being treated with methylphenidate? Can J Psychiatry (1992) 37:570–572.[Web of Science][Medline]
30 Sherman M, Hertzig ME. Prescribing practices of Ritalin: the Suf-folk Country, New York study. In: Ritalian: Theory and Patient Management—Greenhill LL, Osman BB, eds. (1991) New York: Mary Ann Liebert. 187–193.
31 Zito JM, Safer DJ, dosReis S, et al. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med (1999) 153:1257–63.
32 Habel LA, Schaefer CA, Levine P, et al. Treatment with stimulants among youths in a large California health plan. J Child Adolesc Psychopharmacol (2005) 15:62–67.[CrossRef][Web of Science][Medline]
33 Wolraich ML. Attention deficit hyperactivity disorder: the most studied and yet most controversial diagnosis. Ment Retard Dev Disabilities Res Rev (1999) 5:163–168.[CrossRef]
34 Anastopoulos AD, Barkley RA, Shelton TL. Family-based treatment: psychosocial intervention for children & adolescents with ADHD. In: Psychosocial Treatments for Child and Adolescent Disorders—Hibbs ED, Jensen PS, eds. (1996) Washington, DC: American Psychological Association. 267–284.
35 Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study: comparing comborbid subgroups. J Am Acad Child Adolesc Psychiatry (2001) 40:147–158.[CrossRef][Web of Science][Medline]
36 DuPaul G, Stoner G. ADHD in the Schools: Assessment and Intervention Strategies. (2003) New York: Guilford Press.
37 Pelham WE, Wheeler T, Chronis A. Empirically supported psychosocial treatments for attention-deficit hyperactivity disorder. J Clin Child Psychol (1998) 27:190–205.[CrossRef][Web of Science][Medline]
38 Epstein M, Shaywitz S, Shaywitz B, Woolston J. The boundaries of attention deficit disorder. J Learn Disabil (1991) 24:78–86.
39 Zarin DA, Suarez AP, Pincus HA, et al. Clinical and treatment characteristics of children with attention-deficit/hyperactivity disorder in psychiatric practice. J Am Acad Child Adolesc Psychiatry (1998) 37:1262–1270.[CrossRef][Web of Science][Medline]
40 Bussing R, Zima BT, Belin TR. Variations in ADHD treatment among special education students. J Am Acad Child Adolesc Psychiatry (1998) 37:968–976.[CrossRef][Web of Science][Medline]
41 Wasserman RC, Kelleher KJ, Bocian A, et al. Identification of attentional and hyperactivity problems in primary care: a report from Pediatric Research in Office Settings and the Ambulatory Sentinel Practice Network. Pediatrics (1999) 103:E38.[CrossRef][Medline]
42 Wolraich ML, Lindgren S, Stromquist A, et al. Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder. Pediatrics (1990) 86:95–101.
43 US Department of Justice. A guide to disability rights laws (2005) Accessed September 10, 2006. Available at: http://www.usdoj.gov/crt/ada/cguide.htm.
44 US Department of Education. Children with ADD/ADHD—topic brief. In: ED.gov (1999) Accessed September 10, 2006. Available at: http://www.ed.gov/print/policy/speced/leg/idea/brief6.html.
45 Jerome L, Gordon M, Hustler P. A comparison of American and Canadian teachers' knowledge and attitudes towards attention deficit hyperactivity disorder (ADHD). Can J Psychiatry (1994) 39:563–567.[Web of Science][Medline]
46 Wolraich M, Bickman L, Lambert W, et al. Intervening to improve communication among parents, teachers, and primary care providers of children with ADHD or at high risk for ADHD. J Attention Disord (2005) 9:354–368.[Abstract]
47 Schlitt J, Ricket K, Montgomery L, Lear J. State initiatives to support school-based health centers: a national survey. J Adolesc Health (1995) 17:68–76.[CrossRef][Web of Science][Medline]
48 Hoagwood K, Kelleher KJ, Feil M, Comer DM. Treatment services for children with ADHD: a national perspective. J Am Acad Child Adolesc Psychiatry (2000) 39:198–206.[CrossRef][Web of Science][Medline]
49 Chan E, Hopkins JR, Perrin JM, et al. Diagnostic practices for attention deficit hyperactivity disorder: a national survey of primary care physicians. Ambul Pediatr (2005) 5:201–208.[CrossRef][Web of Science][Medline]
50 Stevens J, Harman JS, Kelleher KJ. Ethnic and regional differences in primary care visits for attention-deficit hyperactivity disorder. J Dev Behav Pediatr (2004) 25:318–325.[CrossRef][Web of Science][Medline]
51 Centers for Disease Control and Prevention. Mental health in the United States: prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder—United States, 2003. MMWR Morb Mortal Wkly Rep (2005) 54:842–847.[Medline]
52 Greenhill LL. Diagnosing attention-deficit/hyperactivity disorder in children. J Clin Psychiatry (1998) 59(suppl 7):31–41.[Web of Science][Medline]
53 Elia J, Ambrosini PJ, Rapoport JL. Treatment of attention-deficit hyperactivity disorder. N Engl J Med (1999) 340:780–788.
54 Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA (1998) 279:1100–1107.
55 Gibbs N. The age of Ritalin. Time (1998) 152(22):86–96.[Medline]
56 Wren A. ADHD: dangers of pill popping. Psychology Today (2005) 38–40.
57 National Institutes of Health. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD). (1998) Accessed September 10, 2006. NIH Consensus Statement Online, 16, 1–37 Available at: http://consensus.nih.gov/1998/1998AttentionDeficitHyperactivityDisorder110html.htm.
58 American Academy of Child and Adolescent Psychiatry. Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry (2001) 40:1352–1355.[CrossRef][Web of Science][Medline]
59 Zito JM, Safer DJ, DosReis S, et al. Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med (2003) 157:17–25.
60 Safer DJ, Krager JM. A survey of medication treatment for hyperactive/inattentive students. JAMA (1988) 260:2256–2258.
61 Safer DJ, Zito JM, Fine EM. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics (1996) 98:1084–1088.
62 Olfson M, Gameroff MJ, Marcus SC, Jensen PS. National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry (2003) 160:1071–1077.
63 Angold A, Costello EJ, Farmer EMZ, et al. Impaired but undiagnosed. J Am Acad Child Adolesc Psychiatry (1999) 38:129–137.[CrossRef][Web of Science][Medline]
64 Bauermeister JJ, Canino G, Bravo M, et al. Stimulant and psychosocial treatment of ADHD in Latino/Hispanic children. J Am Acad Child Adolesc Psychiatry (2003) 42:851–855.[CrossRef][Web of Science][Medline]
65 Bussing R, Zima BT, Perwien AR, et al. Children in special education programs: attention deficit hyperactivity disorder, use of services, and unmet needs. Am J Public Health (1998) 88:880–886.
66 Bussing R, Zima BT, Mason D, et al. Use and persistence of pharmacotherapy for elementary school students with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2005) 15:78–87.[CrossRef][Web of Science][Medline]
67 Cox ER, Motheral BR, Henderson RR, Mager D. Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample. Pediatrics (2003) 111:237–243.
68 Leslie LK, Canino G, Landsverk J, et al. ADHD treatment patterns of youth served in public sectors in San Diego and Puerto Rico. Emotional Behav Dis (2005) 13:224–236.[CrossRef]
69 Rowland AS, Umbach DM, Stallone L, et al. Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina. Am J Public Health (2002) 92:231–234.
70 Safer DJ, Malever M. Stimulant treatment in Maryland public schools. Pediatrics (2000) 106:533–539.
71 Stevens J, Harman JS, Kelleher KJ. Race/ethnicity and insurance status as factors associated with ADHD treatment patterns. J Child Adolesc Psychopharmacol (2005) 15:88–96.[CrossRef][Web of Science][Medline]
72 Zito JM, Safer DJ, Riddle MA, et al. Prevalence variations in psychotropic treatment of children. J Child Adolesc Psychopharmacol (1998) 8:99–105.[Web of Science][Medline]
73 Hoagwood K, Jensen PS, Feil M, et al. Medication management of stimulants in pediatric practice settings: a national perspective. J Dev Behav Pediatr (2000) 21:322–331.[Web of Science][Medline]
74 Radigan M, Lannon P, Roohan P, Gesten F. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population. J Child Adolesc Psychopharmacol (2005) 15:44–56.[CrossRef][Web of Science][Medline]
75 Jensen PS, Kettle L, Roper MT, et al. Are stimulants overprescribed? Treatment of ADHD in four US communities. J Am Acad Child Adolesc Psychiatry (1999) 38:797–804.[CrossRef][Web of Science][Medline]
76 Angold A, Erkanli A, Egger HL, Costello EJ. Stimulant treatment for children: a community perspective. J Am Acad Child Adolesc Psychiatry (2000) 39:975–984.[CrossRef][Web of Science][Medline]
77 Zito JM, Safer DJ, dosReis S, et al. Methylphenidate patterns among Medicaid youths. Psychopharmacol Bull (1997) 33:143–147.[Web of Science][Medline]
78 Shatin D, Drinkard CR. Ambulatory use of psychotropics by employer-insured children and adolescents in a national managed care organization. Ambul Pediatr (2002) 2:111–119.[CrossRef][Web of Science][Medline]
79 Horwitz SM, Leaf PJ, Leventhal JM, et al. Identification and management of psychosocial and developmental problems in community-based, primary care pediatric practices. Pediatrics (1992) 89:480–485.
80 Achenbach TM, Bird HR, Canino G, et al. Epidemiological comparisons of Puerto Rican and US mainland children: parent, teacher, and self-reports. J Am Acad Child Adolesc Psychiatry (1990) 29:84–93.[Web of Science][Medline]
81 Crijnen AAM, Achenbach TM, Verhulst FC. Problems reported by parents of children in multiple cultures: the Child Behavior Checklist syndrome constructs. Am J Psychiatry (1999) 156:569–574.
82 Bussing R, Gary FA, Mills TL, Garvan CW. Parental explanatory models of ADHD: gender and cultural variations. Soc Psychiatry Psychiatr Epidemiol (2003) 38:563–575.[CrossRef][Web of Science][Medline]
83 DosReis S, Zito JM, Safer DJ, et al. Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder. J Dev Behav Pediatr (2003) 24:155–162.[Web of Science][Medline]
84 Perwien A, Hall J, Swensen A, Swindle R. Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/hyperactivity disorder. J Manag Care Pharm (2004) 10:122–129.[Medline]
85 Stein B, Orlando M. ADHD treatment in a behavioral health care carve-out: medications, providers, and service utilization. J Behav Health Serv Res (2001) 28:30–41.[CrossRef][Web of Science][Medline]
86 Zima BT, Hurlburt MS, Knapp P, et al. Quality of publicly-funded outpatient specialty mental health care for common childhood psychiatric disorders in California. J Am Acad Child Adolesc Psychiatry (2005) 44:130–144.[CrossRef][Web of Science][Medline]
87 Odom S, Brantlinger E, Gersten R, et al. Research in special education: scientific methods and evidence-based practices. Exceptional Children (2005) 71:137–148.[Web of Science]
88 Garland A, Hurlburt MS, Hawley KM. Examining psychotherapy processes in a service research contest. Clin Psych Sci Practice (2006) 13:30–46.[CrossRef]
89 Weersing VR, Weisz JR, Donenberg GR. Development of the Therapy Procedures Checklist: a therapist-report measure of technique use in child and adolescent treatment. J Clin Child Adolesc Psychol (2002) 31:168–180.[CrossRef][Web of Science][Medline]
90 Hogue A, Liddle H, Dauber S, Samoulis J. Linking session focus to treatment outcome in evidence-based treatments for adolescent substance abuse. Psychother Theory Res Pract Train (2004) 41:83–96.[CrossRef]
91 Hogue A, Liddle H, Rowe C, et al. Treatment adherence and differentiation in individual versus family therapy for adolescent substance abuse. J Counseling Psychol (1998) 45:104–114.[CrossRef][Web of Science]
92 Markowitz J, Spielman L, Scarvalone P, Perry S. Psychotherapy adherence of therapists treating HIV-positive patients with depressive symptoms. J Psychother Pract Res (2000) 9:75–80.
93 McLeod B, Weisz J. The therapy process observational coding system-alliance scale: Measure characteristics and predictions of outcome in usual clinical practice. J Consol Clin Psychol (2005) 73:323–333.[CrossRef]
94 Task Force on Promotion and Dissemination of Psychological Procedures Division of Clinical Psychology. Training in and dissemination of empirically-validated psychological treatments: reports and recommendations. Clin Psychol (1995) 48:3–23.
95 Kanouse DE, Jacoby I. When does information change practitioners' behavior? Int J Technol Assess Health Care (1988) 4:27–33.[Medline]
96 Agency for Health Care Policy and Research. Translating Evidence into Practice: What Do We Know? What Do We Need? (1997) Washington, DC.
97 Agency for Health Care Policy and Research. Translating Evidence Into Practice. (1998) Washington, DC.
98 National Institute of Mental Health. Blueprint for Change: Research on Child and Adolescent Mental Health. (2001) Bethesda, MD.
99 US Public Health Service Office of the Surgeon General. Report of the Surgeon General's Conference on Children's Mental Health: A National Action Agenda. (2000) US Department of Health and Human Services, Washington, DC.
100 Hoagwood K, Burns BJ, Kiser L, et al. Evidence-based practice in child and adolescent mental health services. Psychiatr Serv (2001) 52:1179–1189.
101 Leslie LK, Weckerly J, Plemmons D, et al. Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings. Pediatrics (2004) 114:129–140.
102 Perrin JM, Fluet C, Kuhlthau KA, et al. Benefits for employees with children with ADHD: findings from the Collaborative Employee Benefit Study. J Dev Behav Pediatr (2005) 26:3–8.[Web of Science][Medline]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. J. Marks, A. Mlodnicka, M. Bernstein, A. Chacko, S. Rose, and J. M. Halperin Profiles of Service Utilization and the Resultant Economic Impact in Preschoolers With Attention Deficit/Hyperactivity Disorder J. Pediatr. Psychol., July 1, 2009; 34(6): 681 - 689. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||